Download PDF
1 / Pages

Other users also viewed these articles

Massive data screening is a second opportunity to improve the management of patients with familial hypercholesterolemia phenotype Alberto Zamora; Guillem Paluzie; Joan García-Vilches; Oriol Alonso Gisbert; Ana Inés Méndez Martínez; Núria Plana; Cèlia Rodríguez-Borjabad; Daiana Ibarretxe; Anabel Martín-Urda; Luis Masana;
Clin Investig Arterioscler. 2021;33:138-47
The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis Jose A. Quesada; Vicente Bertomeu-González; Domingo Orozco-Beltrán; Alberto Cordero; Vicente F. Gil-Guillén; Adriana López-Pineda; Rauf Nouni-García; Concepción Carratalá-Munuera;
Clin Investig Arterioscler. 2023;35:165-77
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU) Lluís Masana; José López Miranda; Fernando Civeira; Leonardo Reinares; Carlos Guijarro; Núria Plana; Rafael Cuenca; Demetrio Sánchez; José Luis Hernández; Raimundo Andrés; Agustín Blanco; Santiago Villamayor;
Clin Investig Arterioscler. 2020;32:183-92